Pathology
Lynch Syndrome Screening by IHC Leads to Mutation Studies
Lynch syndrome or hereditary nonpolyposis colorectal cancer is an autosomal dominant genetic condition that is associated with a high risk of colon cancer, as well as other cancers including endometrial cancer, ovary, stomach, small intestine, hepatobiliary tract, upper urinary tract, brain, and skin. More...24 Oct 2019
Presepsin Concentrations Correlate with Kidney Function Decline
Sepsis is an important public health problem with more than 750,000 patients reported yearly in the USA with similar figures in Europe. Sepsis continues to be a challenge for practitioners, as sepsis mortality rates are still high despite new antimicrobial and resuscitation agents. More...24 Oct 2019
Methylation Signature Identified for Brain Metastases of Lung Cancer
When lung cancer metastasizes to the brain, it means the primary lung cancer has created a secondary cancer in the brain. About 20% to 40% of adults with non-small cell lung cancer go on to develop brain metastases at some point during their illness. More...17 Oct 2019
Triple-Negative Breast Cancer Classified from Whole-Genome Sequencing
A diagnosis of triple negative breast cancer means that the three most common types of receptors known to fuel most breast cancer growth–estrogen, progesterone and the HER-2/neu gene are not present in the cancer tumor. More...16 Oct 2019
Multigene Testing for Breast Cancer Patients Proves Cost-Effective
Health systems in the UK and USA could cost-effectively screen all women with breast cancer for risky germline changes in a handful of breast or ovarian cancer genes, according to a new economic modeling analysis, identifying at-risk individuals who could benefit from additional imaging tests and cancer-reducing interventions. More...16 Oct 2019
New Blood Test Capable of Detecting Multiple Cancer Types
A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows. In study, test proved able to detect and localize more than 20 types of cancer with a high degree of accuracy. More...16 Oct 2019
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Urine Chemistry Control
Dropper Urine Chemistry Control
 Analyzer.jpg)
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
In Other News
Blood Monocyte Functions Altered in Parkinson's Disease
Hematological Parameters Detect Patients with Acute VTE
Targeted RNA Sequencing Technology Diagnoses Breast Cancer
Biomarker in Adolescence Linked to Early Mortality
Diagnostic Panel Analysis of Lung Cancer Compared
Diagnostic Biomarker Expression Compared for Metastatic Tumors
Differences in Gut Bacteria May Predispose to Heart Attacks
Chronic Lymphocytic Leukemia Linked with Higher Melanoma Risk
Protein Panel Developed for Early Detection of Lung Cancer
Pathogenic Germline Variants Found in Breast Cancer Patients
Gut Bacteria Linked to High Blood Pressure and Depression
Vaping Illness Characterized by Lipid-Laden Cells in Lungs
New Blood Test Helps Detect Brain Injury in Minutes
Gout Increases Risk of Advanced Chronic Kidney Disease
Blood Sugar Levels Affect Risks in Type 1 Diabetes
CTC Purification Enables Identification of Cancer-Linked Genetic Arrangements
Proteinuria Contributes to Greater CKD Progression Risk in Men
Hormone Levels of Diabetic Men Not Related to Prostate Cancer Risk
Circulating Tumor Cells Directly Detected in Blood Samples
Combination of Gene Mutations Linked to Endometrial Cancer
Non-Invasive Imaging Detects Cancer at Molecular Level
Prognostic Value of Specific Biomarker in Prostate Cancer Authenticated
Pancreatic Cancer Risk Rises with Fasting Glucose
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.